A detailed history of Ameritas Investment Partners, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 39,059 shares of BMRN stock, worth $2.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
39,059
Previous 40,387 3.29%
Holding current value
$2.6 Million
Previous $3.33 Million 17.44%
% of portfolio
0.09%
Previous 0.12%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$69.02 - $93.84 $91,658 - $124,619
-1,328 Reduced 3.29%
39,059 $2.75 Million
Q2 2024

Aug 13, 2024

BUY
$74.43 - $92.22 $3.01 Million - $3.72 Million
40,387 New
40,387 $3.33 Million
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $251,448 - $312,362
-3,463 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$71.87 - $131.03 $8,408 - $15,330
-117 Reduced 3.27%
3,463 $263,000
Q4 2019

Feb 13, 2020

BUY
$64.27 - $86.37 $14,267 - $19,174
222 Added 6.61%
3,580 $303,000
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $7,472 - $8,732
93 Added 2.85%
3,358 $288,000
Q4 2018

Feb 12, 2019

BUY
$80.14 - $106.07 $11,700 - $15,486
146 Added 4.68%
3,265 $278,000
Q3 2018

Nov 13, 2018

SELL
$93.92 - $105.72 $657 - $740
-7 Reduced 0.22%
3,119 $302,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,126
3,126 $284,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.